Hefei TNJ Chemical Industry Co., Ltd., a leading manufacturer and supplier in China, is proud to introduce its latest product - CAS 892570-95-5. This chemical compound, also known as Moxetumomab Pasudotox, is a monoclonal antibody that has been approved for the treatment of hairy cell leukemia.
Moxetumomab Pasudotox works by targeting CD22 receptors on the surface of leukemia cells, ultimately leading to the destruction of the cancerous cells. This makes it an important treatment option for patients who have previously undergone chemotherapy and have not responded sufficiently.
At Hefei TNJ Chemical Industry Co., Ltd., we understand the importance of quality and efficacy when it comes to pharmaceuticals. That's why we strive to deliver only the highest-quality products to meet the needs of our clients. With CAS 892570-95-5, we are proud to offer a potential life-saving treatment option for patients suffering from hairy cell leukemia.